Cargando…

Assessment in vitro of interactions between anti-cancer drugs and noncancer drugs commonly used by cancer patients

Cancer patients often suffer from cancer symptoms, treatment complications and concomitant diseases and are, therefore, often treated with several drugs in addition to anticancer drugs. Whether such drugs, here denoted as ‘concomitant drugs’, have anticancer effects or interact at the tumor cell lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andersson, Claes R., Ye, Jiawei, Blom, Kristin, Fryknäs, Mårten, Larsson, Rolf, Nygren, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Preclinical Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760465/ https://www.ncbi.nlm.nih.gov/pubmed/36066384 http://dx.doi.org/10.1097/CAD.0000000000001344

Ejemplares similares

Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
por: Nygren, Peter, et al.
Publicado: (2013)

Mebendazole is unique among tubulin-active drugs in activating the MEK–ERK pathway
por: Andersson, Claes R., et al.
Publicado: (2020)

Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance
por: Fryknäs, Mårten, et al.
Publicado: (2013)

In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index
por: Kashif, M., et al.
Publicado: (2015)

Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing
por: Rubin, Jenny, et al.
Publicado: (2018)

Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death
por: Selvin, Tove, et al.
Publicado: (2023)

Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
por: Blom, Kristin, et al.
Publicado: (2019)

Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma
por: Ek, Frida, et al.
Publicado: (2022)

Selective radiosensitization by nitazoxanide of quiescent clonogenic colon cancer tumour cells
por: Karlsson, Henning, et al.
Publicado: (2022)

Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome
por: Bjersand, Kathrine, et al.
Publicado: (2022)

Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases
por: Cashin, Peter H, et al.
Publicado: (2023)

Bliss and Loewe interaction analyses of clinically relevant drug combinations in human colon cancer cell lines reveal complex patterns of synergy and antagonism
por: Kashif, Muhammad, et al.
Publicado: (2017)

Single-cell transcriptional pharmacodynamics of trifluridine in a tumor-immune model
por: Selvin, Tove, et al.
Publicado: (2022)

Hypoxia as a target for drug combination therapy of liver cancer
por: Bowyer, Cressida, et al.
Publicado: (2017)

Effects of hypoxia on human cancer cell line chemosensitivity
por: Strese, Sara, et al.
Publicado: (2013)

Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapy
por: Hultman, Bo, et al.
Publicado: (2014)

FOXA1 is a determinant of drug resistance in breast cancer cells
por: Kumar, Uttom, et al.
Publicado: (2021)

Identification of a Novel Topoisomerase Inhibitor Effective in Cells Overexpressing Drug Efflux Transporters
por: Fayad, Walid, et al.
Publicado: (2009)

N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug target
por: Mackey, John R., et al.
Publicado: (2021)

Searching for essential genes and drug discovery in breast cancer and periodontitis via text mining and bioinformatics analysis
por: Luo, Lan, et al.
Publicado: (2021)

Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
por: Saeed, Mohamed E. M., et al.
Publicado: (2020)

The availability of drug by liposomal drug delivery: Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphate
por: Smits, Evelien A. W., et al.
Publicado: (2018)

A novel ligand of the translationally controlled tumor protein (TCTP) identified by virtual drug screening for cancer differentiation therapy
por: Fischer, Nicolas, et al.
Publicado: (2021)

S-Adenosyl-l-methionine-competitive inhibitors of the histone methyltransferase EZH2 induce autophagy and enhance drug sensitivity in cancer cells
por: Liu, Tsang-Pai, et al.
Publicado: (2015)

A novel tumor spheroid model identifies selective enhancement of radiation by an inhibitor of oxidative phosphorylation
por: Karlsson, Henning, et al.
Publicado: (2019)

Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles
por: Rickardson, L, et al.
Publicado: (2005)

Identification of Common Genes Refers to Colorectal Carcinogenesis with Paired Cancer and Noncancer Samples
por: Zhang, Lihua, et al.
Publicado: (2018)

A better experimental method to detect the sensitivity of cancer cells to anticancer drugs after adenovirus-mediated introduction of two kinds of p53 in vivo
por: Wang, Hui, et al.
Publicado: (2015)

Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing
por: Wu, Yonghui, et al.
Publicado: (2019)

Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells
por: Pandiri, Indira, et al.
Publicado: (2016)

The Wnt-dependent signaling pathways as target in oncology drug discovery
por: Janssens, Nico, et al.
Publicado: (2006)

Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis
por: McAleese, Courtney E., et al.
Publicado: (2022)

Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance.
por: Dhar, S., et al.
Publicado: (1996)

Development of a dietary formulation of the SHetA2 chemoprevention drug for mice
por: Benbrook, Doris M., et al.
Publicado: (2017)

A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer
por: Yuan, Danping, et al.
Publicado: (2022)

Paclitaxel Drug-Coated Balloon Angioplasty Suppresses Progression and Inflammation of Experimental Atherosclerosis in Rabbits
por: Chowdhury, Mohammed M., et al.
Publicado: (2020)

Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial
por: Strell, Carina, et al.
Publicado: (2021)

Drug penetration enhancement techniques in ablative fractional laser assisted cutaneous delivery of indocyanine green
por: Meesters, Arne A., et al.
Publicado: (2019)

Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes
por: Byrgazov, Konstantin, et al.
Publicado: (2021)

Social interaction reward in rats has anti‐stress effects
por: Lemos, Cristina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_096sa0f8ic7d12uhhmj6s4hq9g